Congress Asset Management Co. cut its position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 3.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 261,728 shares of the semiconductor company’s stock after selling 8,284 shares during the quarter. Congress Asset Management Co. owned approximately 0.14% of Synopsys worth $122,939,000 at the end of the most recent quarter.
Several other institutional investors also recently added to or reduced their stakes in SNPS. Manchester Capital Management LLC lifted its stake in Synopsys by 5.3% in the second quarter. Manchester Capital Management LLC now owns 340 shares of the semiconductor company’s stock valued at $174,000 after buying an additional 17 shares during the last quarter. Barden Capital Management Inc. grew its position in shares of Synopsys by 1.2% during the fourth quarter. Barden Capital Management Inc. now owns 1,868 shares of the semiconductor company’s stock worth $877,000 after acquiring an additional 23 shares during the last quarter. Mutual Advisors LLC grew its position in shares of Synopsys by 2.1% during the third quarter. Mutual Advisors LLC now owns 1,157 shares of the semiconductor company’s stock worth $528,000 after acquiring an additional 24 shares during the last quarter. Alpine Bank Wealth Management increased its holdings in shares of Synopsys by 89.3% in the 3rd quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock valued at $26,000 after acquiring an additional 25 shares during the period. Finally, Valeo Financial Advisors LLC increased its holdings in shares of Synopsys by 3.9% in the 3rd quarter. Valeo Financial Advisors LLC now owns 666 shares of the semiconductor company’s stock valued at $329,000 after acquiring an additional 25 shares during the period. Institutional investors and hedge funds own 85.47% of the company’s stock.
Analysts Set New Price Targets
SNPS has been the subject of a number of recent research reports. Wells Fargo & Company decreased their price target on shares of Synopsys from $500.00 to $450.00 and set an “equal weight” rating for the company in a research note on Thursday, February 26th. Citigroup began coverage on shares of Synopsys in a report on Monday, November 24th. They issued a “buy” rating and a $580.00 target price for the company. Wall Street Zen upgraded shares of Synopsys from a “sell” rating to a “hold” rating in a research note on Saturday, December 13th. Needham & Company LLC reissued a “buy” rating on shares of Synopsys in a report on Thursday, February 26th. Finally, Rosenblatt Securities dropped their price target on Synopsys from $560.00 to $530.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Eight research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $531.00.
Insider Activity at Synopsys
In other Synopsys news, insider Janet Lee sold 250 shares of the business’s stock in a transaction on Monday, January 12th. The stock was sold at an average price of $530.00, for a total transaction of $132,500.00. Following the sale, the insider directly owned 11,959 shares in the company, valued at approximately $6,338,270. The trade was a 2.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.56% of the stock is owned by company insiders.
Key Headlines Impacting Synopsys
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Elliott Investment Management has taken a multibillion‑dollar position and intends to push Synopsys for higher software monetization and margins, prompting an investor rally. Activist Elliott Builds Big Stake in Chip-Design Software Maker Synopsys
- Positive Sentiment: Market coverage and media reports (CNBC, Reuters) amplified the story, driving buying interest as investors highlight Synopsys’s central role in AI chip design and potential for re‑rating. Synopsys shares rally as activist Elliott builds multibillion-dollar stake in chip design firm
- Positive Sentiment: Analyst and social commentary emphasize structural AI tailwinds and Synopsys’s EDA leadership — investors see scope for higher margins if execution improves under activist pressure. An Activist Investor Is Taking an Interest in This Nvidia Partner. Its Stock Is Rising.
- Neutral Sentiment: Synopsys’s strategic shift after the Ansys acquisition and its Converge 2026 messaging position it more towards system‑level and AI solutions; this supports longer‑term growth but raises integration execution oversight. How The Synopsys (SNPS) Story Is Shifting With The Ansys Deal And 2026 Uncertainty
- Negative Sentiment: Recent insider selling (multiple officers have sold shares in the past six months) could be viewed negatively by some investors as a signal of limited near‑term insider confidence. Synopsys Stock (SNPS) Opinions on Elliott Activist Stake
- Negative Sentiment: Activist involvement brings execution risk and potential strategic changes that could create short‑term volatility; some analysts remain cautious after recent underperformance. Activist Elliott takes multibillion-dollar stake in Synopsys, WSJ reports
Synopsys Stock Performance
Shares of SNPS opened at $432.48 on Tuesday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.26 and a current ratio of 1.36. The stock has a market capitalization of $82.85 billion, a P/E ratio of 67.16, a P/E/G ratio of 3.42 and a beta of 1.15. The company’s fifty day moving average is $451.31 and its two-hundred day moving average is $455.34. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73.
Synopsys (NASDAQ:SNPS – Get Free Report) last posted its quarterly earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.56 by $0.21. The firm had revenue of $2.41 billion during the quarter, compared to analysts’ expectations of $2.39 billion. Synopsys had a net margin of 13.76% and a return on equity of 6.83%. The firm’s revenue for the quarter was up 65.6% on a year-over-year basis. During the same period in the prior year, the company posted $3.03 earnings per share. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. On average, sell-side analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current year.
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Further Reading
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
